search
Back to results

Project UPLIFT to Reduce Anxiety and Depression in CF Patients

Primary Purpose

Cystic Fibrosis, Anxiety, Depression

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
UPLIFT
Treatment as usual
Sponsored by
Virginia Commonwealth University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Cystic Fibrosis focused on measuring cystic fibrosis, mindfulness, cognitive behavioral therapy, UPLIFT, anxiety, depression, web based intervention

Eligibility Criteria

13 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

*Please note that only patients who are seen by one of our participating CF clinics (listed in "locations") will be approached about UPLIFT (if eligible) during this phase of the UPLIFT project.*

Inclusion Criteria:

First, patients will have to agree to have their contact information shared with the study team in order to be eligible.

Eligibility criteria:

  • have been diagnosed with CF for at least 1 year;
  • score 5-14 on the GAD-7 and/or a 5-19 on the PHQ-9;
  • be ≥13 years of age;
  • be English speaking; and
  • not have a prominent cognitive impairment.

Exclusion Criteria:

  • Persons reporting active suicidal ideation on the PHQ-9 will be excluded.

Sites / Locations

  • Virginia Commonwealth University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

UPLIFT

Control Group

Arm Description

The Project UPLIFT intervention was designed for delivery to groups of six to eight people by telephone or Internet, though for this study the intervention will be web based only. The telephone intervention comprised eight hour-long sessions, each including check-in, instruction, skill building, and discussion, with homework between sessions. The Web intervention contains the same elements: check-in, video instruction, skill building, a discussion board, and homework between sessions. Instruction focuses on increasing knowledge about depression, cystic fibrosis (CF), cognitive behavioral therapy (CBT), and mindfulness and skills related to CBT and mindfulness.

Treatment-as-usual

Outcomes

Primary Outcome Measures

Reduce symptoms of anxiety among UPLIFT Tx Group participants.
Anxiety symptoms will be assessed with the Generalized Anxiety Disorder-7 (GAD-7)
Reduce symptoms of depression among UPLIFT Tx Group participants.
Depressive Symptoms will be assessed with the Patient Health Questionnaire-9 (PHQ-9).

Secondary Outcome Measures

Increase quality of life among UPLIFT Tx Group participants.
Quality of Life will be assessed using the Cystic Fibrosis Questionnaire-Revised (CFQ-R).
Increase satisfaction with life among UPLIFT Tx Group participants.
Satisfaction with life will be measured using the Satisfaction with Life Scale.
Improve knowledge and skills regarding self-management of anxiety and depression among UPLIFT Tx Group participants.
Will be assessed using an 18-item true-false measure developed during the development of Project UPLIFT.
Increase self-efficacy among UPLIFT Tx Group participants.
We will measure this using the Depression Coping Self-Efficacy Scale (DCSES).

Full Information

First Posted
April 24, 2017
Last Updated
June 2, 2023
Sponsor
Virginia Commonwealth University
Collaborators
University of Michigan, Boston Children's Hospital, University at Buffalo, Emory University, Children's Hospital Medical Center, Cincinnati, Johns Hopkins University, Cystic Fibrosis Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT03139266
Brief Title
Project UPLIFT to Reduce Anxiety and Depression in CF Patients
Official Title
Project UPLIFT to Reduce Anxiety and Depression in CF Patients
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Completed
Study Start Date
April 7, 2015 (Actual)
Primary Completion Date
August 2, 2022 (Actual)
Study Completion Date
August 2, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Virginia Commonwealth University
Collaborators
University of Michigan, Boston Children's Hospital, University at Buffalo, Emory University, Children's Hospital Medical Center, Cincinnati, Johns Hopkins University, Cystic Fibrosis Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
People with CF have elevated rates of anxiety and depression when compared to the general population. Anxiety and depression can have a negative impact on adherence and disease self-management, leading to worse CF health outcomes such as respiratory symptoms, functional capacity, and health-related quality of life (HRQOL). Project UPLIFT is a group mental health intervention that can be delivered by telephone or Web, though for this study the intervention will be web based only. Project UPLIFT was originally developed as a depression treatment and prevention program for people with epilepsy and was shown to be effective in reducing depression and increasing knowledge and skills. Recently, Project UPLIFT was revised to help people with CF manage their depression and anxiety and shown to be apparently successful in a pilot study that included adolescents and adults with CF. The goals of this project are to determine the effectiveness of Project UPLIFT in reducing anxiety and depression in adolescents and adults with CF, as well as increasing their quality of life and other physical health-related disease outcomes.
Detailed Description
The Project UPLIFT intervention was designed for delivery to groups of six to eight people by telephone or Internet, though for this study the intervention will be web based only. The telephone intervention comprised eight hour-long sessions, each including check-in, instruction, skill building, and discussion, with homework between sessions. The Web intervention contains the same elements: check-in, video instruction, skill building, a discussion board, and homework between sessions. Instruction focuses on increasing knowledge about depression, CF, CBT, and mindfulness and skills related to CBT and mindfulness. Participation in the sessions involves skills practice, discussions, and group exercises based on the sessions' main topics. CBT-related topics include thought monitoring, identifying cognitive distortions, self-esteem, problem identification, goal setting, and identifying supports. Relaxation exercises, including a body scan (i.e., a mindfulness exercise) and progressive muscle relaxation, are also used for coping and to facilitate awareness of the body. Mindfulness activities include attention to skin, sights, and sounds and other meditations. Participants will practice their skills between sessions through homework assignments including monitoring and changing thoughts, and practicing relaxation exercises, meditation exercises, and mindfulness. A week's homework is discussed at the beginning of the next session. The program is designed to guide participants from noticing, challenging, and changing thoughts (CBT components), to staying in the present moment with acceptance of and nonreactivity to those thoughts (mindfulness components). All sessions will be co-facilitated by a layperson with CF and a doctoral student in psychology, supervised by a licensed clinical psychologist. Once the subjects are recruited and enrolled, baseline assessment will take place and then they will be randomized into the intervention group or treatment-as-usual control group condition (recommendation to consider obtaining mental health services). All participants will complete questionnaires via the internet. Following the initial assessment, the groups will receive their assigned intervention (or control treatment) and there will be questionnaire based testing of mental health, QoL, and disease management at 2 months (immediately following the group intervention), 6 months, and 12 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cystic Fibrosis, Anxiety, Depression
Keywords
cystic fibrosis, mindfulness, cognitive behavioral therapy, UPLIFT, anxiety, depression, web based intervention

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
85 (Actual)

8. Arms, Groups, and Interventions

Arm Title
UPLIFT
Arm Type
Experimental
Arm Description
The Project UPLIFT intervention was designed for delivery to groups of six to eight people by telephone or Internet, though for this study the intervention will be web based only. The telephone intervention comprised eight hour-long sessions, each including check-in, instruction, skill building, and discussion, with homework between sessions. The Web intervention contains the same elements: check-in, video instruction, skill building, a discussion board, and homework between sessions. Instruction focuses on increasing knowledge about depression, cystic fibrosis (CF), cognitive behavioral therapy (CBT), and mindfulness and skills related to CBT and mindfulness.
Arm Title
Control Group
Arm Type
Other
Arm Description
Treatment-as-usual
Intervention Type
Behavioral
Intervention Name(s)
UPLIFT
Intervention Description
Participation in the sessions involves skills practice, discussions, and group exercises based on the sessions' main topics. CBT-related topics include thought monitoring, identifying cognitive distortions, self-esteem, problem identification, goal setting, and identifying supports. Relaxation exercises, including a body scan (i.e., a mindfulness exercise) and progressive muscle relaxation, are also used for coping and to facilitate awareness of the body. Mindfulness activities include attention to skin, sights, and sounds and other meditations. Participants will practice their skills between sessions through homework assignments including monitoring and changing thoughts, and practicing relaxation exercises, meditation exercises, and mindfulness.
Intervention Type
Behavioral
Intervention Name(s)
Treatment as usual
Intervention Description
The control group will receive the recommendation to consider maintaining mental health services
Primary Outcome Measure Information:
Title
Reduce symptoms of anxiety among UPLIFT Tx Group participants.
Description
Anxiety symptoms will be assessed with the Generalized Anxiety Disorder-7 (GAD-7)
Time Frame
Baseline (at 0 week), Tx End (at 8 weeks), Follow-up (at 6 months post Tx End), Extended Follow-up (at 12 months post Tx End)
Title
Reduce symptoms of depression among UPLIFT Tx Group participants.
Description
Depressive Symptoms will be assessed with the Patient Health Questionnaire-9 (PHQ-9).
Time Frame
Baseline (at 0 week), Tx End (at 8 weeks), Follow-up (at 6 months post Tx End), Extended Follow-up (at 12 months post Tx End)
Secondary Outcome Measure Information:
Title
Increase quality of life among UPLIFT Tx Group participants.
Description
Quality of Life will be assessed using the Cystic Fibrosis Questionnaire-Revised (CFQ-R).
Time Frame
Baseline (at 0 week), Tx End (at 8 weeks), Follow-up (at 6 months post Tx End), Extended Follow-up (at 12 months post Tx End)
Title
Increase satisfaction with life among UPLIFT Tx Group participants.
Description
Satisfaction with life will be measured using the Satisfaction with Life Scale.
Time Frame
Baseline (at 0 week), Tx End (at 8 weeks), Follow-up (at 6 months post Tx End), Extended Follow-up (at 12 months post Tx End)
Title
Improve knowledge and skills regarding self-management of anxiety and depression among UPLIFT Tx Group participants.
Description
Will be assessed using an 18-item true-false measure developed during the development of Project UPLIFT.
Time Frame
Baseline (at 0 week), Tx End (at 8 weeks), Follow-up (at 6 months post Tx End), Extended Follow-up (at 12 months post Tx End)
Title
Increase self-efficacy among UPLIFT Tx Group participants.
Description
We will measure this using the Depression Coping Self-Efficacy Scale (DCSES).
Time Frame
Baseline (at 0 week), Tx End (at 8 weeks), Follow-up (at 6 months post Tx End), Extended Follow-up (at 12 months post Tx End)
Other Pre-specified Outcome Measures:
Title
(Exploratory) Change in CF disease severity status.
Description
CF disease related measures will be collected from routine clinic visits that occur from the time of enrollment to final UPLIFT follow-up
Time Frame
Baseline (at 0 week), Tx End (at 8 weeks), Follow-up (at 6 months post Tx End), Extended Follow-up (at 12 months post Tx End)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
13 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
*Please note that only patients who are seen by one of our participating CF clinics (listed in "locations") will be approached about UPLIFT (if eligible) during this phase of the UPLIFT project.* Inclusion Criteria: First, patients will have to agree to have their contact information shared with the study team in order to be eligible. Eligibility criteria: have been diagnosed with CF for at least 1 year; score 5-14 on the GAD-7 and/or a 5-19 on the PHQ-9; be ≥13 years of age; be English speaking; and not have a prominent cognitive impairment. Exclusion Criteria: Persons reporting active suicidal ideation on the PHQ-9 will be excluded.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael S Schechter, MD, MPH
Organizational Affiliation
Virginia Commonwealth University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Virginia Commonwealth University
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23298
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Project UPLIFT to Reduce Anxiety and Depression in CF Patients

We'll reach out to this number within 24 hrs